Literature DB >> 9017855

Molecular genetics and its application to cardiac muscle disease.

R Roberts1.   

Abstract

The application of the techniques of recombinant DNA and molecular biology to molecular genetics has made it possible to identify any disease-related gene in which there is a family of 2 or more generations with 10 or more living affected individuals. Several genes have been identified that are responsible for cardiomyopathies and of particular interest is familial hypertrophic cardiomyopathy which is the most common cause of death in the athlete. Pre-screening for genetic abnormalities will be possible prior to the development of symptoms and, ultimately, such testing will also be used to specify the type of exercise to be recommended for different types of athletic training or exercise needs.

Entities:  

Mesh:

Year:  1997        PMID: 9017855     DOI: 10.2165/00007256-199723010-00001

Source DB:  PubMed          Journal:  Sports Med        ISSN: 0112-1642            Impact factor:   11.928


  31 in total

Review 1.  Molecular biology for the cardiologist.

Authors:  A Mares; J Towbin; R D Bies; R Roberts
Journal:  Curr Probl Cardiol       Date:  1992-01       Impact factor: 5.200

2.  Molecular genetics. Therapy or terror?

Authors:  R Roberts
Journal:  Circulation       Date:  1994-01       Impact factor: 29.690

3.  Differences in clinical expression of hypertrophic cardiomyopathy associated with two distinct mutations in the beta-myosin heavy chain gene. A 908Leu----Val mutation and a 403Arg----Gln mutation.

Authors:  N D Epstein; G M Cohn; F Cyran; L Fananapazir
Journal:  Circulation       Date:  1992-08       Impact factor: 29.690

4.  Heterologous expression of a cardiomyopathic myosin that is defective in its actin interaction.

Authors:  H L Sweeney; A J Straceski; L A Leinwand; B A Tikunov; L Faust
Journal:  J Biol Chem       Date:  1994-01-21       Impact factor: 5.157

Review 5.  Molecular genetics of hypertrophic cardiomyopathy.

Authors:  A J Marian; R Roberts
Journal:  Annu Rev Med       Date:  1995       Impact factor: 13.739

6.  Angiotensin-converting enzyme polymorphism in hypertrophic cardiomyopathy and sudden cardiac death.

Authors:  A J Marian; Q T Yu; R Workman; G Greve; R Roberts
Journal:  Lancet       Date:  1993-10-30       Impact factor: 79.321

7.  Localization of a gene responsible for familial dilated cardiomyopathy to chromosome 1q32.

Authors:  J B Durand; L L Bachinski; L C Bieling; G Z Czernuszewicz; A B Abchee; Q T Yu; T Tapscott; R Hill; J Ifegwu; A J Marian
Journal:  Circulation       Date:  1995-12-15       Impact factor: 29.690

Review 8.  Causes of sudden death in competitive athletes.

Authors:  B J Maron; S E Epstein; W C Roberts
Journal:  J Am Coll Cardiol       Date:  1986-01       Impact factor: 24.094

9.  A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis.

Authors:  E J Weiss; P F Bray; M Tayback; S P Schulman; T S Kickler; L C Becker; J L Weiss; G Gerstenblith; P J Goldschmidt-Clermont
Journal:  N Engl J Med       Date:  1996-04-25       Impact factor: 91.245

Review 10.  Sudden cardiac death in patients with hypertrophic cardiomyopathy: from bench to bedside with an emphasis on genetic markers.

Authors:  A J Marian
Journal:  Clin Cardiol       Date:  1995-04       Impact factor: 2.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.